Related Experiment Video
Updated: Apr 29, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
CaMKII and stress mix it up in mitochondria
Mei-Ling A Joiner1, Olha M Koval1
1Internal Medicine/Cardiology, University of Iowa Iowa City, IA, USA.
Insights
Mitochondrial CaMKII worsens heart injury by opening the mitochondrial permeability transition pore (mPTP). Inhibiting CaMKII in heart mitochondria may protect against heart disease by suppressing mPTP opening.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Molecular Cardiology
Background:
- Calcium/calmodulin-dependent protein kinase II (CaMKII) is found in heart mitochondria.
- Mitochondrial CaMKII contributes to adverse outcomes following cardiac injury.
- Pathological conditions such as myocardial infarction (MI) and ischemia reperfusion (IR) involve mitochondrial CaMKII.
Purpose of the Study:
- To investigate the role of mitochondrial CaMKII in heart disease.
- To explore the mechanism by which CaMKII inhibition impacts mitochondrial function.
- To address the question of how CaMKII localizes to mitochondria.
Main Methods:
- Utilized a CaMKII inhibitor (CaMKIIN) targeted to myocardial mitochondria.
- Employed electrophysiological experiments to assess mitochondrial function.
- Investigated Ca(2+) signaling pathways within mitochondria.
Main Results:
- CaMKII inhibition suppressed the opening of the mitochondrial permeability transition pore (mPTP).
- CaMKII inhibition reduced Ca(2+) entry into mitochondria, likely preventing mPTP opening.
- The study identified CaMKII as a key player in mitochondrial dysfunction after heart injury.
Conclusions:
- Mitochondrial CaMKII is a significant contributor to heart disease progression.
- Inhibiting mitochondrial CaMKII may offer a therapeutic strategy for cardiac protection.
- Further research is needed to understand CaMKII's mitochondrial translocation and broader signaling network.
Abstract:
CaMKII is a newly discovered resident of mitochondria in the heart. Mitochondrial CaMKII promotes poor outcomes after heart injury from a number of pathological conditions, including myocardial infarction (MI), ischemia reperfusion (IR), and stress from catecholamine stimulation. A study using the inhibitor of CaMKII, CaMKIIN, with expression delimited to myocardial mitochondria, indicates that an underlying cause of heart disease results from the opening of the mitochondrial permeability transition pore (mPTP). Evidence from electrophysiological and other experiments show that CaMKII inhibition likely suppresses mPTP opening by reducing Ca(2+) entry into mitochondria. However, we expect other proteins involved in Ca(2+) signaling in the mitochondria are affected with CaMKII inhibition. Several outstanding questions remain for CaMKII signaling in heart mitochondria. Most importantly, how does CaMKII, without the recognized N-terminal mitochondrial targeting sequence transfer to mitochondria?
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Mitochondrial Membranes
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

